Biotech

Coverage of the strategies, challenges, and innovations defining the current state of biotech in the healthcare space.

Photo of a school, J&J logo, and a hand with a needle in a petri dish
Pharma

North Carolina’s Research Triangle sees big investments despite NIH cuts

Johnson & Johnson, Amgen, and Fujifilm Biotechnologies have all recently invested in the RTP.

Cassie McGrath
Sign outside of Regeneron Pharmaceuticals on Tuesday, Aug. 6, 2013 in East Greenbush, N.Y.
Pharma

What 23andMe’s Regeneron sale means for the industry

This completes the company’s yearslong fall from its $6 billion peak.

Caroline Catherman
Two businessmen's arms shaking hands with pharma pills covering one hand and biotech graphics covering the other
Pharma

3 major biotechs make acquisitions

J&J, Eli Lilly, and GSK all made deals on Monday morning.

Cassie McGrath
Kelly MacDonald
Pharma

How one biotech CFO prioritizes and learns from her people

Dynavax’s CFO Kelly MacDonald on learning from unexpected sources and asking the right questions.

Natasha Piñon
A group of people cluster outside the now-defunct Silicon Valley Bank
Pharma

Biotech may not be able to fend off M&A in the coming months, experts say

Biotech has worked hard to fend off M&A. In the wake of a bank collapse and a tightening lending market, that could be coming to an end.

Kristen Talman, Maia Anderson

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew